A traditional Japanese herbal formula called juzentaihoto improved bone density and strength in aging mice by reactivating multiple bone-building pathways, according to Gram Research analysis of a 2026 study. The treatment restored genes involved in bone formation, mineralization, and bone cell development without requiring vitamin D or other common bone-health mechanisms. While these laboratory findings are promising for age-related bone loss prevention, human clinical trials are needed before the formula can be recommended as a medical treatment.
Researchers tested a traditional Japanese herbal medicine called juzentaihoto (JTT) on mice that age quickly and develop weak bones similar to elderly humans. According to Gram Research analysis, the formula helped restore bone density and activated multiple biological pathways that strengthen bones. The treatment worked by restarting the body’s natural bone-building process without relying on vitamin D or other common bone-health pathways. These findings suggest JTT could potentially help older adults maintain stronger bones, though human studies are still needed to confirm these results.
Key Statistics
A 2026 research study found that juzentaihoto treatment increased cortical bone mass and improved bone mineral density in genetically aging mice, suggesting the formula reactivates the body’s natural bone-remodeling process.
According to the 2026 bone research, juzentaihoto restored expression of genes responsible for collagen biosynthesis, osteoblast differentiation, and bone mineralization—three critical processes for building strong bones.
The 2026 study showed juzentaihoto also increased antioxidant enzyme expression and reduced abnormal neurotransmitter signaling in bone tissue, suggesting multiple protective mechanisms beyond direct bone-cell effects.
Research published in Bone Reports in 2026 demonstrated that juzentaihoto’s bone-strengthening effects occurred without activating vitamin D or Klotho-FGF23 pathways, indicating a novel mechanism distinct from conventional bone-health approaches.
The Quick Take
- What they studied: Whether a traditional Japanese herbal formula called juzentaihoto could help prevent bone loss and weakness that happens with aging
- Who participated: Laboratory mice that were genetically modified to age rapidly and develop osteoporosis (weak, brittle bones) similar to elderly humans
- Key finding: Mice treated with juzentaihoto showed improved bone density and stronger cortical bone (the hard outer layer of bones), suggesting the formula reactivated the body’s natural bone-rebuilding process
- What it means for you: This research suggests a natural herbal approach might help prevent age-related bone loss, but human studies are needed before it can be recommended as a treatment. Talk to your doctor before trying any new supplements.
The Research Details
Scientists used specially bred mice that age very quickly and naturally develop weak bones similar to what happens in elderly humans. These mice were given juzentaihoto, a traditional Japanese herbal medicine made from multiple plant ingredients that has been used clinically for centuries. The researchers measured bone density using advanced imaging technology (micro-computed tomography) to see if the treatment improved bone strength.
To understand how the formula worked, the team analyzed the genes expressed in bone tissue using RNA sequencing—essentially reading the genetic instructions that tell cells what to do. They identified which genes were turned on or off in response to the treatment, then confirmed their findings using additional genetic testing methods. This approach revealed the biological mechanisms behind the formula’s effects.
This research approach is important because it bridges traditional medicine with modern molecular science. Rather than just measuring whether bones got stronger, the researchers identified the specific biological pathways the formula activates. This helps explain why it works and suggests it might be effective in humans. The use of aging-model mice makes the findings more relevant to elderly people who actually experience age-related bone loss.
The study used rigorous molecular analysis techniques and validated findings through multiple testing methods. However, this is laboratory research in mice, not human studies. The sample size of mice was not specified in the abstract. Results in mice don’t always translate to humans, so larger human clinical trials would be needed to confirm these findings are safe and effective for people.
What the Results Show
Juzentaihoto treatment improved bone mineral density and increased the thickness of cortical bone (the dense outer layer that provides strength) in aging mice. The formula also increased cortical void volume, which suggests it reactivated the body’s natural bone remodeling process—the continuous cycle where old bone is removed and new bone is built.
The genetic analysis revealed that juzentaihoto restored expression of genes responsible for building collagen (the protein scaffold of bone), helping bone-forming cells (osteoblasts) develop, and promoting mineralization (the process that makes bone hard and strong). The formula also influenced genes related to bone-breaking cells (osteoclasts), suggesting it balanced the bone formation-and-breakdown cycle that becomes imbalanced with aging.
Beyond bone-specific effects, juzentaihoto reduced abnormal signaling related to neurotransmitters (chemical messengers in the body) and increased expression of genes that produce antioxidant enzymes. Antioxidants protect cells from damage caused by aging and stress. These additional effects suggest the formula supports overall bone health through multiple mechanisms beyond just bone cell activity.
This research expands on previous knowledge that juzentaihoto helps maintain overall health in elderly people. While the formula has been used clinically for this purpose, its specific effects on bone health and the molecular mechanisms involved were not well understood. This study provides the first detailed genetic explanation of how the formula might prevent age-related bone loss, filling an important gap in scientific understanding of traditional Japanese medicine.
This study was conducted entirely in laboratory mice with a genetic condition that causes rapid aging. Results in mice don’t always translate to humans—the formula might work differently, less effectively, or have different side effects in people. The study didn’t test the formula against standard bone-loss treatments, so we don’t know how it compares to existing medications. Human clinical trials are essential before juzentaihoto can be recommended as a bone-health treatment. The specific sample size of mice used was not reported, making it harder to assess statistical power.
The Bottom Line
Based on this laboratory research, juzentaihoto shows promise as a potential treatment for age-related bone loss. However, confidence in this recommendation is currently low because human studies haven’t been conducted. Do not start taking juzentaihoto for bone health without consulting your doctor. If you’re concerned about bone loss, discuss proven approaches like weight-bearing exercise, adequate calcium and vitamin D intake, and bone density screening with your healthcare provider.
This research is most relevant to elderly adults concerned about osteoporosis and bone fragility, and to researchers studying traditional medicine and aging. It may also interest people seeking natural alternatives to conventional bone-loss treatments. However, until human studies are completed, this remains experimental. People with kidney disease, those taking medications that affect bone health, and pregnant or nursing women should definitely consult doctors before considering any new supplement.
In the mice studied, bone improvements were measurable through imaging and genetic analysis, but the timeframe isn’t specified in the research. If human trials eventually confirm these findings, benefits would likely take weeks to months to become noticeable, similar to other bone-health interventions. Bone is a slow-changing tissue, so patience is required with any treatment approach.
Frequently Asked Questions
Can juzentaihoto prevent osteoporosis in older adults?
Laboratory research shows juzentaihoto improved bone density in aging mice by activating bone-building genes, but human studies haven’t been conducted yet. Current evidence is too preliminary to recommend it for osteoporosis prevention without medical supervision.
How does juzentaihoto strengthen bones differently than vitamin D?
The 2026 research found juzentaihoto works through multiple pathways including collagen production and bone cell activation, but doesn’t require vitamin D or related mechanisms. This suggests it may complement rather than replace conventional bone-health approaches.
Is juzentaihoto safe for elderly people with weak bones?
While juzentaihoto has been used traditionally in Japanese medicine for elderly health, safety and effectiveness in people with osteoporosis haven’t been formally tested. Always consult your doctor before starting any supplement, especially if you take bone medications.
When would I see bone strength improvements from juzentaihoto?
This study didn’t specify the timeframe for improvements in mice. Bone changes typically develop slowly over weeks to months. Any human treatment would require regular monitoring through bone density scans and medical supervision.
What’s the difference between this research and actual bone treatments?
This is laboratory research in mice, not human clinical trials. While findings are scientifically rigorous, results in mice don’t always translate to humans. FDA-approved bone medications have undergone extensive human testing; juzentaihoto has not.
Want to Apply This Research?
- Track bone health markers monthly: record any changes in bone pain, fracture risk factors (falls, balance issues), and supplement adherence if you’re using juzentaihoto under medical supervision. Note dietary calcium and vitamin D intake daily.
- If your doctor approves, log daily juzentaihoto dosage and timing in your app. Pair this with tracking weight-bearing exercise (walking, strength training) and dietary sources of calcium and vitamin D—all factors that support bone health based on established research.
- Set quarterly reminders to assess bone health through DEXA scans (if recommended by your doctor) and track any changes in bone-related symptoms. Monitor for any side effects or interactions with other medications. Share this data with your healthcare provider to evaluate whether the supplement is working for your individual situation.
This research is laboratory-based in mice and has not been tested in humans. Juzentaihoto is not FDA-approved for treating osteoporosis or bone loss. Do not use this information to replace medical advice from your doctor. If you have osteoporosis, bone loss, or are concerned about bone health, consult your healthcare provider about proven treatments and screening options. Before starting any herbal supplement, especially if you take medications affecting bone health, kidney function, or calcium metabolism, discuss it with your doctor to avoid interactions and ensure safety.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.